SLN360
Silence Therapeutics
[]
$sln silence therapeutics presents new analysis from sln360 phase 1 single dose study in high lipoprotein(a) at the american heart association (aha) 2022 annual meeting stock news alerts in bio
Over 500 members. DM us for our premium stock alerts.